Lumea
Jared Szymanski is a founding partner and pathologist at ConnectPathology. He is also a founding partner at LUMEA, a company that develops tools for digital pathology. Previously, he owned Jared L Szymanski DO PC, providing anatomic and clinical pathology services in the Urban South region for Intermountain Health Care. He has held various positions such as pathologist at Utah Valley Regional Medical Center, managing partner at ValuePath, and clinical chemistry lab director at Myriad Genetics. Jared Szymanski has a diverse educational background with degrees in Osteopathic Medicine, MBA, Spanish, and zoology from Arizona School of Osteopathic Medicine and Brigham Young University.
Lumea
Lumea is reshaping the pathology landscape with innovative technology solutions that elevate and enhance the entire pathology ecosystem. Since its founding in 2013, Lumea has pioneered one of the first software platforms of its kind, offering a comprehensive suite of products, including proprietary specimen-handling consumables, a digitally-enabled Laboratory Information System (LIS), and a premier IMS/Viewer. Lumea’s unique approach to digital pathology not only increases cancer detection rates but also delivers a substantial return on investment in a cost-sensitive environment and ultimately sets a higher standard of patient care in cancer diagnostics. With over 1.5 million digital diagnoses, Lumea ranks among the top 5 digital pathology platforms for clinical use in the United States. For further insights into the transformative benefits of Lumea technology, visit lumeadigital.com.